Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung CancersCIRB: Adult CIRB - Late Phase EmphasisLead Group: ECOG-ACRINStatus: ActiveReview Status: Available to Open
